large intestinal cancer tumors of the colon and/or rectum
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Prospective study: - Men and women aged 18 years or older; - Established diagnosis of stage I, II or III CRC, including recurrent CRC., Cross-sectional study: - Men and women aged 18 years or older; - History of stage I, II or III CRC, including recurrent CRC, for which the cases concerned received treatment in the preceding 2 to 10 years.
Exclusion criteria
Exclusion criteria: Prospective study: - Established diagnosis of stage IV CRC; - CRC survivors with a current home address not in the Netherlands; - Inability to understand the Dutch language in speech as well as in writing (e.g. reading disorders or illiteracy); - Presence of comorbidities that may obstruct successful participation, including cognitive disorders such as Alzheimer*s disease or aphasia, and severe visibility or hearing disorders such as complete blindness and/or deafness. , Cross-sectional study: - History of stage IV CRC in the preceding 2 to 10 years; - Former stage I to III CRC cases who are not alive at present; - CRC survivors with a current home address not in the Netherlands; - Inability to understand the Dutch language in speech as well as in writing (e.g. reading disorders or illiteracy); - Presence of comorbidities that may obstruct successful participation, including cognitive disorders such as Alzheimer*s disease or aphasia, and severe visibility or hearing disorders such as complete blindness and/or deafness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main outcome parameter is (change in) quality of life of colorectal cancer survivors, and main determinants are (changes in) physical activity and dietary factors. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters are biomedical, personal, and environmental factors related to (specific aspects of) quality of life, physical activity, and diet of colorectal cancer survivors (as depicted in Fig. 1 on p. 12 of the research protocol). | — |
Countries
Netherlands